The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease

Back

ESC Premium Access

The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease

Session: Hypertension e-posters

Topic: Pharmacotherapy

Speaker: Mrs O. Obertynska (Vinnitsa, UA)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Mrs Oksana Obertynska

National Pirogov Memorial Medical University, Vinnitsa (Ukraine)

0 follower

110 more presentations in this session

Exercise intensities modulate cognitive function in spontaneously hypertensive rats through oxidative mediated synaptic plasticity in hippocampus

Speaker: Professor T. Lee (Tainan, TW)

Access

Abstract

Slides

Arterial stiffness and the risk of heart failure formation in rotational shift workers in the arctic

Speaker: Doctor N. Shurkevich (Tyumen, RU)

Access

Abstract

Slides

Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial

Speaker: Doctor M. Pareek (Copenhagen, DK)

Access

Abstract

Slides

Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)

Speaker: Doctor M. Pareek (Copenhagen, DK)

Access

Abstract

Slides

Renal denervation in truly resistant hypertensive patients: six-year follow-up results of a single-center study

Speaker: Doctor M. Ionov (Saint Petersburg, RU)

Access

Abstract

Slides

Access the full session

Hypertension e-posters

Speakers: Mrs O. Obertynska, Professor T. Lee, Doctor N. Shurkevich, Doctor M. Pareek, Doctor M. Pareek...

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources